Cision PR Newswire

Likang Life Sciences Showcases Personalized Cancer Immunotherapy and Global Ambitions at Abu Dhabi Future Health Summit 2026

BEIJING, Oct. 24, 2026 /PRNewswire/ -- Likang Life Sciences ("Likang"), a biotechnology company advancing AI-enabled personalized cancer immunotherapies, sponsored and exhibited at the Abu Dhabi Future Health Summit 2026, held from 20 to 22 October at ADNEC Centre Abu Dhabi. The summit marked a milestone in Likang's international outreach, showcasing...

2026 China Marine Economy Expo Kicks Off: Embarking Together on a Journey Toward Digital and Smart Ocean

SHENZHEN, China, Oct. 24, 2026 /PRNewswire/ -- On October 22, Shenzhen World Exhibition & Convention...

ASTRI Showcases Pioneering Technologies at InnoCarnival 2026

Driving Technology Adoption, Shaping a Vision for the Future HONG KONG, Oct. 24,...

HKAGE Showcases Gifted Students’ Learning Journeys at InnoCarnival 2026

Promoting "Technology for Good" Through Innovation and Creativity  HONG KONG, Oct. 24, 2026...

e& reports AED 19.4 billion consolidated revenue, with 15.1% YoY growth in Q1 2026

"e& continues to deliver growth, with consolidated revenues of AED 19.4 billion and EBITDA of AED 8.6 billion, marking year-on-year increases...

Nearly 90 percent of companies believe people will determine AI success, but far fewer are investing in related people strategies, Inaugural Aon Study Finds

DUBLIN, April 28, 2026 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm, today released its inaugural Human Capital Trends Study,...

Creating a Sustainable Impact: Fosun International Releases 2025 ESG Report and Climate Information Disclosures Report

HONG KONG, April 28, 2026 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group"), released...

ACROBiosystems Wins CiteAb Award, Gaining Worldwide Recognition

SAN DIEGO and NEWARK, Del., April 28, 2026 /PRNewswire/ -- Recently, ACROBiosystems was honored as a "Protein Supplier to Watch in Cancer Research in 2026"...